Computational Approaches in Preclinical Studies on Drug Discovery and Development

Abstract

Because undesirable pharmacokinetics and toxicity are significant reasons for the failure of drug development in the costly late stage, it has been widely recognized that drug ADMET properties should be considered as early as possible to reduce failure rates in the clinical phase of drug discovery. Concurrently, drug recalls have become increasingly common in recent years, prompting pharmaceutical companies to increase attention toward the safety evaluation of preclinical drugs. In vitro and in vivo drug evaluation techniques are currently more mature in preclinical applications, but these technologies are costly. In recent years, with the rapid development of computer science, in silico technology has been widely used to evaluate the relevant properties of drugs in the preclinical stage and has produced many software programs and in silico models, further promoting the study of ADMET in vitro. In this review, we first introduce the two ADMET prediction categories (molecular modeling and data modeling). Then, we perform a systematic classification and description of the databases and software commonly used for ADMET prediction. We focus on some widely studied ADMT properties as well as PBPK simulation, and we list some applications that are related to the prediction categories and web tools. Finally, we discuss challenges and limitations in the preclinical area and propose some suggestions and prospects for the future.

Effects of Aloe vera Flower Extract and Its Active Constituent Isoorientin on Skin Moisturization via Regulating Involucrin Expression: In Vitro and Molecular Docking Studies

“…Over time, molecular docking studies are carried out to explore the protein and ligand interactions in a precise way [ 31 ]. From the obtained results, IO showed the highest docking score towards p38, ERK and PKC with a binding affinity −8.3 kcal/mol and −8.1 kcal/mol respectively.…”

Physicochemical, ADMET and Druggable properties of Myricetin: A Key Flavonoid in Syzygium cumini that regulates metabolic inflammations

“…Selected phytocompounds were subjected to M prediction using i rop (version 4.3, uite 20 5-chro dinger, New York, NY) and toxicity prediction using TOPKAT (Accelrys, Inc., USA). Qik-Prop develops and employs QSAR/QSPR models using partial least squares, principal component analysis and multiple linear regression to predict physicochemically significant descriptors 23 . Druggabiity scores were computed using FAF-Drugs4 (28961788)/ FAF-QED ( 28961788) -open-source CIP.…”

Progress on open chemoinformatic tools for expanding and exploring the chemical space

“…The review also covered compound databases that provide different information relevant to drug discovery, such as approved drugs, patented molecules or small molecules commercially available. Wu et al surveyed databases and software commonly used to predict ADME/Tox-related properties [ 32 ].…”